SVRA logo

Savara Inc. (SVRA)

Profile

Full Name

Savara Inc.

Ticker

NASDAQ: SVRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 28, 2017

Indexes

Not included

Website

https://www.savarapharma.com

Employees

59

Key Details

Price

$3.61(+1.40%)

Market cap

$623.94M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$0.48(-45.45% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.61
    SVRA price is $3.61

    30-Day Relative Volume

    0.44
    SVRA 30-day relative volume is 0.44

    Price Performance

    Price Today change

    +1.4%
    SVRA price is up +1.4% today

    Price YTD change

    +17.59%
    SVRA price is up +17.59% since January 1st

    Price 1-year change

    -14.05%
    SVRA price is down -14.05% year-on-year

    Price 3-year change

    +142.28%
    SVRA price is up +142.28% over the past 3 years

    Price Range

    Price All-time high

    $17.19
    SVRA price is currently -79.00% below its historical high of $17.19

    Price 3-year low

    $1.08
    SVRA price is currently +234.26% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $623.94M
    SVRA market capitalization is $623.94 million

    Market cap 3-year change

    +267.19%
    SVRA market capitalization is up +267.19% over the past 3 years

    Market cap All-time high

    $833.69M
    SVRA market capitalization is currently -25.16% below its historical high of $833.69 million

    Market cap sector rank

    66.44%
    SVRA market capitalization is higher than 66.44% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5%
    SVRA shares outstanding is up +5% year-on-year

    Shares Outstanding 3-Year Change

    +51.55%
    SVRA shares outstanding is up +51.55% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.83
    SVRA beta is 0.83

    200-day SMA

    $2.84
    SVRA price is currently +27.14% above its 200-day simple moving average

    50-day SMA

    $2.88
    SVRA price is currently +25.34% above its 50-day simple moving average

    RSI

    65.60
    SVRA 14-day relative strength index is 65.60

    Volume

    0.44
    SVRA 30-day relative volume is 0.44

    ATR

    $0.19
    SVRA average true range is $0.19

    10-day Historical Volatility

    51.23%
    SVRA 10-day historical volatility is 51.23%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    SVRA annual revenue is $0.00

    Revenue Analysts estimate

    -
    SVRA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    SVRA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    SVRA annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$0.48
    SVRA annual earnings per share is -$0.48

    EPS Analysts estimate

    -$0.52
    SVRA annual earnings per share is currently -6.98% lower than the consensus analysts' forecast

    EPS 1-year change

    -45.45%
    SVRA annual earnings per share is down -45.45% year-on-year

    EPS Sector rank

    63.03%
    SVRA annual earnings per share is higher than 63.03% of companies in Healthcare sector

    Profit

    Gross profit

    -$275.00K
    SVRA annual gross profit is -$275.00 thousand

    Gross margin

    -
    SVRA annual gross profit margin value is unknown

    Operating profit

    -$102.40M
    SVRA annual operating income is -$102.40 million

    Operating margin

    -
    SVRA annual operating profit margin value is unknown

    Net income

    -$95.88M
    SVRA annual net profit is -$95.88 million

    Net margin

    -
    SVRA annual net profit margin value is unknown

    Expenses

    Total expenses

    $102.40M
    SVRA annual total expenses is $102.40 million

    Operating expenses

    $102.40M
    SVRA annual total operating expenses is $102.40 million

    Cost of goods sold

    $275.00K
    SVRA annual cost of goods sold is $275.00 thousand

    Selling, general & administrative expenses

    $25.04M
    SVRA annual SGA is $25.04 million

    Depreciation and amortization

    $130.00K
    SVRA annual depreciation & amortization is $130.00 thousand

    Interest expense

    $0.00
    SVRA annual interest expense is $0.00

    Income tax

    $0.00
    SVRA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$102.40M
    SVRA annual earnings before interest & taxes is -$102.40 million

    EBITDA

    -$102.27M
    SVRA annual EBITDA is -$102.27 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $212.88M
    SVRA annual total assets is $212.88 million

    Non current assets

    $10.74M
    SVRA annual long term assets is $10.74 million

    Current assets

    $202.13M
    SVRA annual total current assets is $202.13 million

    Cash and cash equivalents

    $15.13M
    SVRA annual cash & cash equivalents is $15.13 million

    Accounts receivable

    -
    SVRA annual accounts receivable value is unknown

    Inventory

    $0.00
    SVRA annual inventory is $0.00

    Liabilities

    Total liabilities

    $41.43M
    SVRA annual total liabilities is $41.43 million

    Long term liabilities

    $26.71M
    SVRA annual total long term liabilities is $26.71 million

    Current liabilities

    $14.72M
    SVRA annual total current liabilities is $14.72 million

    Accounts payable

    $4.54M
    SVRA annual accounts payable is $4.54 million

    Debt

    Total debt

    $26.82M
    SVRA annual total debt is $26.82 million

    Total debt 1-year change

    +0.31%
    SVRA annual total debt is up +0.31% year-on-year

    Long term debt

    $26.71M
    SVRA annual long term debt is $26.71 million

    Short term debt

    $116.00K
    SVRA annual short term debt is $116.00 thousand

    Equity & Capital

    Shareholders equity

    $171.45M
    SVRA annual stockholders equity is $171.45 million

    Book value

    $171.45M
    SVRA annual book value is $171.45 million

    Retained earnings

    -$489.25M
    SVRA annual retained earnings is -$489.25 million

    Working capital

    $187.41M
    SVRA annual working capital is $187.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$89.09M
    SVRA annual cash flow from operations is -$89.09 million

    Cash from operations 1-year change

    -74.47%
    SVRA annual cash flow from operations is down -74.47% year-on-year

    Cash from investing

    -$39.94M
    SVRA annual cash flow from investing activities is -$39.94 million

    Cash from investing 1-year change

    +30.07%
    SVRA annual cash flow from investing activities is up +30.07% year-on-year

    Cash from financing

    $117.58M
    SVRA annual cash flow from financing activities is $117.58 million

    Cash from financing 1-year change

    +42.04%
    SVRA annual cash flow from financing activities is up +42.04% year-on-year

    CAPEX

    CAPEX

    $25.00K
    SVRA annual capital expenditures is $25.00 thousand

    CAPEX 1-year change

    -91.55%
    SVRA annual capital expenditures is down -91.55% year-on-year

    Free Cash Flow

    Free cash flow

    -$89.11M
    SVRA annual free cash flow is -$89.11 million

    Free cash flow 1-year change

    -73.52%
    SVRA annual free cash flow is down -73.52% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    SVRA annual gross profit margin value is unknown

    Operating margin

    -
    SVRA annual operating profit margin value is unknown

    Net margin

    -
    SVRA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -49.11%
    SVRA annual return on assets is -49.11%

    ROE

    -61.50%
    SVRA annual return on equity is -61.50%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SVRA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SVRA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    5.18
    SVRA price to book ratio is 5.18

    PB ratio Sector rank

    79.21%
    SVRA price to book ratio is higher than 79.21% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    SVRA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    SVRA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $507.24M
    SVRA enterprise value is $507.24 million

    Enterprise value Sector rank

    65.43%
    SVRA enterprise value is higher than 65.43% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.33
    SVRA EV/EBITDA is -4.33

    EV/EBITDA Sector rank

    25.09%
    SVRA EV/EBITDA is higher than 25.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    13.73
    SVRA annual current ratio is 13.73

    Quick ratio

    13.73
    SVRA annual quick ratio is 13.73

    Leverage

    Debt to equity

    0.16
    SVRA annual debt to equity ratio is 0.16

    Interest coverage ratio

    -
    SVRA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    SVRA piotroski f-score value is unknown

    Altman Z-Score

    5.29
    SVRA altman z-score is 5.29

    Analyst ratings

    Recent major analysts updates

    Sep 9, 25 Guggenheim
    Buy
    Sep 8, 25 Oppenheimer
    Outperform
    Sep 3, 25 HC Wainwright & Co.
    Buy
    Aug 15, 25 Oppenheimer
    Outperform
    Aug 15, 25 HC Wainwright & Co.
    Buy
    May 29, 25 HC Wainwright & Co.
    Neutral
    May 28, 25 Wells Fargo
    Overweight
    May 28, 25 Guggenheim
    Buy
    May 28, 25 Evercore ISI Group
    In-Line
    Mar 31, 25 Evercore ISI Group
    Hold

    Institutional Ownership

    Screeners with SVRA included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Savara Inc.?
    • Does Savara Inc. pay dividends?
    • What sector is Savara Inc. in?
    • What industry is Savara Inc. in?
    • What country is Savara Inc. based in?
    • When did Savara Inc. go public?
    • Is Savara Inc. in the S&P 500?
    • Is Savara Inc. in the NASDAQ 100?
    • Is Savara Inc. in the Dow Jones?
    • When was Savara Inc.'s last earnings report?
    • When does Savara Inc. report earnings?

    What is the ticker symbol for Savara Inc.?

    The ticker symbol for Savara Inc. is NASDAQ:SVRA

    Does Savara Inc. pay dividends?

    No, Savara Inc. does not pay dividends

    What sector is Savara Inc. in?

    Savara Inc. is in the Healthcare sector

    What industry is Savara Inc. in?

    Savara Inc. is in the Biotechnology industry

    What country is Savara Inc. based in?

    Savara Inc. is headquartered in United States

    When did Savara Inc. go public?

    Savara Inc.'s initial public offering (IPO) was on April 28, 2017

    Is Savara Inc. in the S&P 500?

    No, Savara Inc. is not included in the S&P 500 index

    Is Savara Inc. in the NASDAQ 100?

    No, Savara Inc. is not included in the NASDAQ 100 index

    Is Savara Inc. in the Dow Jones?

    No, Savara Inc. is not included in the Dow Jones index

    When was Savara Inc.'s last earnings report?

    Savara Inc.'s most recent earnings report was on August 13, 2025

    When does Savara Inc. report earnings?

    The next expected earnings date for Savara Inc. is November 14, 2025
    On this page